Osteopar Liquid
Product Images NDC 44911-0367

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Osteopar (NDC 44911-0367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Energique, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Enrg0861 Osteopar 2 17 21

Enrg0861 Osteopar 2 17 21
This is a warning label for a pain relief medication that may temporarily relieve pain in the lower back, sacroiliac area, joints, and bones. The label warns pregnant or breastfeeding individuals to consult a healthcare professional prior to use, and urges users to keep the medication out of reach of children. In the event of an overdose, medical help or contact with a Poison Control Center should be made immediately. It should not be used if the tamper-evident seal is broken or missing. The medication's traditional homeopathic practice-based claims are not verified by the FDA, with no accepted medical data supporting the claims. Users should seek advice from a health care professional if they experience symptoms for more than seven days, or for use in children under 12.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.